Cresset Asset Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,505
Closed -$250K 1239
2021
Q3
$250K Sell
3,505
-15
-0.4% -$1.18K ﹤0.01% 928
2021
Q2
$286K Buy
+3,520
New +$283K ﹤0.01% 797
2019
Q2
Sell
-87
Closed -$9K 1251
2019
Q1
$9K Sell
87
-2
-2% -$201 ﹤0.01% 1202
2018
Q4
$7K Buy
+89
New +$8.06K ﹤0.01% 934

Other funds holding NGVT

Cresset Asset Management's NGVT Position: Q4 2021 in Review

Cresset Asset Management sold out of Ingevity (NGVT) in Q4 2021, closing a stake of 3,505 shares — an estimated $250K sold.

Cresset Asset Management first reported a position in NGVT in Q4 2018 and held it in 4 quarters. The position peaked at $286K in Q2 2021. 277 funds tracked by Wall St. Rank hold NGVT as of Q4 2021.

  • Cresset Asset Management reported no remaining Ingevity position as of Q4 2021 after selling out during the quarter.
  • Cresset Asset Management sold 3,505 Ingevity shares in Q4 2021, an estimated $250K.
  • Cresset Asset Management first reported a position in Ingevity in Q4 2018 and held it in 4 quarters.
  • Cresset Asset Management's Ingevity position peaked at $286K in Q2 2021.
  • 277 funds tracked by Wall St. Rank held Ingevity as of Q4 2021.

Based on Cresset Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.